Drug information for DILTZAC
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE, EXTENDED RELEASE; ORAL
120MG
Prescription
AB4
DILTIAZEM HYDROCHLORIDE
Diltiazem
APOTEX INC
76395
CAPSULE, EXTENDED RELEASE; ORAL
180MG
Prescription
AB4
DILTIAZEM HYDROCHLORIDE
Diltiazem
APOTEX INC
"
CAPSULE, EXTENDED RELEASE; ORAL
240MG
Prescription
AB4
DILTIAZEM HYDROCHLORIDE
Diltiazem
APOTEX INC
"
CAPSULE, EXTENDED RELEASE; ORAL
300MG
Prescription
AB4
DILTIAZEM HYDROCHLORIDE
Diltiazem
APOTEX INC
"
CAPSULE, EXTENDED RELEASE; ORAL
360MG
Prescription
AB4
DILTIAZEM HYDROCHLORIDE
Diltiazem
APOTEX INC
"
Drug Adverse Effects information for DILTZAC
Role code
Indications
Reaction
# Reports
PS
ATRIAL FIBRILLATION
BLOOD GLUCOSE INCREASED
1
PS
ATRIAL FIBRILLATION
CONVULSION
1
PS
ATRIAL FIBRILLATION
DYSKINESIA
1
PS
ATRIAL FIBRILLATION
EXAGGERATED STARTLE RESPONSE
2
PS
ATRIAL FIBRILLATION
HICCUPS
2
PS
ATRIAL FIBRILLATION
IRON BINDING CAPACITY TOTAL INCREASED
1
PS
ATRIAL FIBRILLATION
MUSCLE SPASMS
1
PS
ATRIAL FIBRILLATION
MUSCLE TWITCHING
1
PS
ATRIAL FIBRILLATION
MYOCLONUS
2
PS
ATRIAL FIBRILLATION
SENSORY DISTURBANCE
1
PS
ATRIAL FIBRILLATION
SERUM FERRITIN DECREASED
1
PS
ATRIAL FIBRILLATION
SLEEP APNOEA SYNDROME
2
PS
ATRIAL FIBRILLATION
STEREOTYPY
1
PS
ATRIAL FIBRILLATION
TRANSFERRIN SATURATION DECREASED
1
PS
HYPERLIPIDAEMIA
BLOOD GLUCOSE INCREASED
2
PS
HYPERLIPIDAEMIA
CONVULSION
2
PS
HYPERLIPIDAEMIA
DYSKINESIA
2
PS
HYPERLIPIDAEMIA
EXAGGERATED STARTLE RESPONSE
4
PS
HYPERLIPIDAEMIA
HICCUPS
4
PS
HYPERLIPIDAEMIA
IRON BINDING CAPACITY TOTAL INCREASED
2
PS
HYPERLIPIDAEMIA
MUSCLE SPASMS
2
PS
HYPERLIPIDAEMIA
MUSCLE TWITCHING
2
PS
HYPERLIPIDAEMIA
MYOCLONUS
4
PS
HYPERLIPIDAEMIA
SENSORY DISTURBANCE
2
PS
HYPERLIPIDAEMIA
SERUM FERRITIN DECREASED
2
PS
HYPERLIPIDAEMIA
SLEEP APNOEA SYNDROME
4
PS
HYPERLIPIDAEMIA
STEREOTYPY
2
PS
HYPERLIPIDAEMIA
TRANSFERRIN SATURATION DECREASED
2
PS
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD GLUCOSE INCREASED
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
CONVULSION
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
DYSKINESIA
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
EXAGGERATED STARTLE RESPONSE
2
PS
PRODUCT USED FOR UNKNOWN INDICATION
HICCUPS
2
PS
PRODUCT USED FOR UNKNOWN INDICATION
IRON BINDING CAPACITY TOTAL INCREASED
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
MUSCLE SPASMS
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
MUSCLE TWITCHING
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
MYOCLONUS
2
PS
PRODUCT USED FOR UNKNOWN INDICATION
SENSORY DISTURBANCE
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
SERUM FERRITIN DECREASED
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
SLEEP APNOEA SYNDROME
2
PS
PRODUCT USED FOR UNKNOWN INDICATION
STEREOTYPY
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
TRANSFERRIN SATURATION DECREASED
1
PS
SUPRAVENTRICULAR TACHYCARDIA
BLOOD GLUCOSE INCREASED
1
PS
SUPRAVENTRICULAR TACHYCARDIA
CONVULSION
1
PS
SUPRAVENTRICULAR TACHYCARDIA
DYSKINESIA
1
PS
SUPRAVENTRICULAR TACHYCARDIA
EXAGGERATED STARTLE RESPONSE
2
PS
SUPRAVENTRICULAR TACHYCARDIA
HICCUPS
2
PS
SUPRAVENTRICULAR TACHYCARDIA
IRON BINDING CAPACITY TOTAL INCREASED
1
PS
SUPRAVENTRICULAR TACHYCARDIA
MUSCLE SPASMS
1
PS
SUPRAVENTRICULAR TACHYCARDIA
MUSCLE TWITCHING
1
PS
SUPRAVENTRICULAR TACHYCARDIA
MYOCLONUS
2
PS
SUPRAVENTRICULAR TACHYCARDIA
SENSORY DISTURBANCE
1
PS
SUPRAVENTRICULAR TACHYCARDIA
SERUM FERRITIN DECREASED
1
PS
SUPRAVENTRICULAR TACHYCARDIA
SLEEP APNOEA SYNDROME
2
PS
SUPRAVENTRICULAR TACHYCARDIA
STEREOTYPY
1
PS
SUPRAVENTRICULAR TACHYCARDIA
TRANSFERRIN SATURATION DECREASED
1
Ads by Google